| The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients M Platzer, D Totschnig, M Karolyi, T Clodi-Seitz, C Wenisch, A Zoufaly Wiener klinische Wochenschrift, 1-7, 2024 | | 2024 |
| Genomic surveillance of SARS-CoV-2 evolution by a centralised pipeline and weekly focused sequencing, Austria, January 2021 to March 2023 O Frank, DA Balboa, M Novatchkova, E Özkan, MM Strobl, R Yelagandula, ... Eurosurveillance 29 (23), 2300542, 2024 | | 2024 |
| Is the T2MR Candida Panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice? I Camp, A Füszl, B Selitsch, I Kröckel, K Kovac, M Wahrmann, ... Clinical Microbiology and Infection 30 (6), 816-821, 2024 | | 2024 |
| Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms BW Citarella, C Kartsonaki, ED Ibánez-Prada, BP Gonçalves, J Baruch, ... Heliyon 10 (10), 2024 | | 2024 |
| Point-of-Care Method T2Bacteria®Panel Enables a More Sensitive and Rapid Diagnosis of Bacterial Blood Stream Infections and a Shorter Time until Targeted … T Clodi-Seitz, S Baumgartner, M Turner, T Mader, J Hind, C Wenisch, ... Microorganisms 12 (5), 967, 2024 | | 2024 |
| Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms A Gavrylov, BW Citarella, C Kartsonaki, ED Ibáñez-Prada, A Zoufaly, ... | | 2024 |
| Long-Term Treatment Success with Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) C Bernardini, W Bauer, S Schellberg, S Scholten, C Stephan, C Wyen, ... healthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses 12 …, 2024 | | 2024 |
| Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital discharge JH Niebauer, A Iscel, S Schedl, C Capelle, M Kahr, S Schamilow, J Faltas, ... Frontiers in Cardiovascular Medicine 11, 1366269, 2024 | | 2024 |
| Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials C Orkin, JM Molina, P Cahn, J Lombaard, K Supparatpinyo, S Kumar, ... The Lancet HIV 11 (2), e75-e85, 2024 | 2 | 2024 |
| Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19 F Camirand-Lemyre, L Merson, BKT Vijayaraghavan, AJC Burrell, ... JAMA Network Open 6 (12), e2346502-e2346502, 2023 | 1 | 2023 |
| 541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression M Platzer, D Totschnig, C Wenisch, A Zoufaly Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 610, 2023 | | 2023 |
| Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial V Rathkolb, MT Traugott, A Heinzel, M Poglitsch, J Aberle, F Eskandary, ... Iscience 26 (11), 2023 | | 2023 |
| Cardiopulmonary long-term impairment in patients 6 and 18 months post severe Covid-19 infection JH Niebauer, A Iscel, S Schedl, C Capelle, M Kahr, S Schamilow, ... European Heart Journal 44 (Supplement_2), ehad655. 206, 2023 | | 2023 |
| Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients C Lichtensteiger, M Koblischke, F Berner, AK Jochum, T Sinnberg, ... Journal of autoimmunity 140, 103118, 2023 | 1 | 2023 |
| Neurological manifestations of COVID-19 in adults and children A Gavrylov, V Tieroshyn, SM Cho, N White, L Premraj, A Zoufaly, ... | | 2023 |
| frontiers Frontiers in Immunology BRIEF RESEARCH REPORT published: 19 July 2022 M Narasimhan, G Grødeland, M Skok, K Stiasny, I Medits, DN Springer, ... Advancing the understanding of emergence of SARS-CoV-2 genetic variants and …, 2023 | | 2023 |
| Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19 T Seitz, F Bergmayr, R Kitzberger, J Holbik, A Grieb, J Hind, F Lucny, ... Frontiers in Physiology 14, 1223347, 2023 | | 2023 |
| Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19 M Wainstein, N Spyrison, D Dai, M Ghadimi, JS Chávez-Iñiguez, ... Kidney international reports 8 (8), 1514-1530, 2023 | 7 | 2023 |
| Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort M Karolyi, A Gruebl, S Omid, M Saak, E Pawelka, W Hoepler, H Kelani, ... Infection 51 (4), 851-858, 2023 | 6 | 2023 |
| Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low-and middle-income … MJ Griffee, PT Bozza, LF Reyes, DP Eddington, D Rosenberger, L Merson, ... Research and practice in thrombosis and haemostasis 7 (5), 102142, 2023 | 2 | 2023 |
